The data displays the leading therapy areas in U.S. medicine spending in 2016. In that year, around 45.5 billion USD were spent on oncologics. Thus, cancer was the number two therapy class in the U.S., behind antidiabetics.
Antidiabetics | 51.5 |
Oncologics | 45.5 |
Autoimmune | 37.2 |
Respiratory | 26 |
Pain | 19.7 |
Nervous system disorders | 19 |
HIV antivirals | 18.8 |
Multiple sclerosis | 18.7 |
Mental health | 17.2 |
Viral hepatitis | 15.7 |
Anticoagulants | 12.5 |
Lipid regulators | 12 |
ADHD | 11.2 |
Dermatologicals | 11 |
Antihypertensives | 9.5 |
Vaccines (excl. flu) | 8.7 |
Other cardiovasculars | 8.3 |
GI products | 8.1 |
Antibacterials | 7.6 |
Sex hormones | 6.6 |